Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
89Zr-DFO-STEAP1 antibody is a radiolabeled monoclonal antibody being developed as an immuno-PET imaging agent and theranostic tool for prostate cancer. It consists of a humanized IgG1 monoclonal antibody targeting six-transmembrane epithelial antigen of the prostate 1 (STEAP1), conjugated to the chelator deferoxamine (DFO) and radiolabeled with the positron-emitting isotope zirconium-89 (89Zr). STEAP1 is highly expressed in prostate cancer, including metastatic castration-resistant prostate cancer (mCRPC), making it an attractive target for patients with low or absent PSMA expression. Preclinical studies at the University of Wisconsin-Madison have demonstrated that the tracer exhibits high tumor uptake and retention with rapid clearance from normal tissues, supporting its potential as a companion diagnostic for STEAP1-targeted therapies.
| Indication | Highest phase | Status |
|---|---|---|
| prostate cancer and precursor lesions | Preclinical | Active |
Every indication, with countries and timelines, is in the full profile.
| Market | Status | Year |
|---|---|---|
| United States | Not approved | — |
| European Union | Not approved | — |
| China | Not approved | — |
| Japan | Not approved | — |
Approved indications and other markets are in the full profile.
Lead indication: prostate cancer and precursor lesions
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on 89Zr-DFO-STEAP1 antibody.
Work on 89Zr-DFO-STEAP1 antibody? Claim this page to correct or add information. Claim this page